Antibody-associated epilepsies: clinical features, evidence for immunotherapies and future research questions
<h4>Objectives</h4> <p>The growing recognition of epilepsies and encephalopathies associated with autoantibodies against surface neuronal proteins (LGI1, NMDAR, CASPR2, GABABR, and AMPAR) means that epileptologists are increasingly asking questions about mechanisms of antibody-medi...
| Autores principales: | , , |
|---|---|
| Formato: | Journal article |
| Publicado: |
Elsevier
2016
|